Novavax, Inc. (NVAX)

Novavax Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1,821	570	807	10,817	7,099	106
Market Cap Growth	12.02%	-29.35%	-92.54%	52.38%	6610.95%	-84.98%
Enterprise Value	1,559	220	10	9,745	6,762	344
PE Ratio	-	-1.05	-1.23	-6.20	-16.97	-0.80
PS Ratio	1.83	0.58	0.41	9.44	14.93	5.67
PB Ratio	-0.77	-0.79	-1.27	-30.76	11.32	-0.57
P/FCF Ratio	-1.30	-0.74	-1.59	40.75	-73.06	-0.88
P/OCF Ratio	-1.42	-0.80	-1.94	33.50	-166.87	-0.77
EV/Sales Ratio	1.56	0.22	0.00	8.50	14.22	18.44
EV/EBITDA Ratio	-1.21	-0.45	-0.02	-5.80	-16.98	-3.04
EV/EBIT Ratio	-1.07	-0.42	-0.02	-5.75	-16.77	-2.89
EV/FCF Ratio	-0.79	-0.29	-0.02	36.71	-69.59	-2.86
Debt / Equity Ratio	-0.26	-0.32	-0.87	-1.29	0.75	-1.72
Debt / EBITDA Ratio	-0.68	-0.47	-0.91	-0.27	-1.18	-2.83
Debt / FCF Ratio	-0.45	-0.30	-1.08	1.71	-4.82	-2.67
Quick Ratio	0.64	0.54	0.58	0.83	1.84	3.48
Current Ratio	0.90	0.70	0.69	0.90	2.15	3.77
Asset Turnover	0.61	0.59	0.79	0.44	0.50	0.10
Interest Coverage	-26.84	-36.67	-31.88	-80.15	-26.62	-8.75
Return on Equity (ROE)	52.90%	71.60%	169.60%	-368.20%	-187.10%	74.60%
Return on Assets (ROA)	-24.60%	-32.60%	-26.40%	-66.40%	-44.20%	-70.90%
Return on Capital (ROIC)	62.50%	116.12%	764.84%	-1648.37%	-38.05%	-89.59%
Earnings Yield	-21.89%	-95.59%	-81.53%	-16.12%	-5.89%	-125.45%
FCF Yield	-28.25%	-135.53%	-63.06%	2.45%	-1.37%	-113.58%
Buyback Yield / Dilution	-62.39%	-28.89%	-5.08%	-29.27%	-138.81%	-30.35%
Total Shareholder Return	-62.39%	-28.89%	-5.08%	-29.27%	-138.81%	-30.35%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).